AstraZeneca confirmed on Wednesday that its COVID-19 vaccine was very effective at preventing the disease.
The Anglo-Swedish drugmaker confirmed this based on more recent data after questions were raised on the interim results of its US clinical trial findings announced on Monday.
Key takeaways
“Positive high-level results from the primary analysis of the phase III trial of AZD1222 in the US have confirmed covid vaccine efficacy.”
“Vaccine well-tolerated, and no safety concerns were identified.”
“76% vaccine efficacy against symptomatic covid.”
Share
